{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:36:40Z","timestamp":1791329800414,"version":"4.3.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":4549,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2001,2]]},"DOI":"10.1006\/viro.2000.0768","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:00:16Z","timestamp":1032426016000},"page":"183-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["The Epstein\u2013Barr Virus Latent Membrane Protein 1 Induces Interleukin-10 in Burkitt's Lymphoma Cells but Not in Hodgkin's Cells Involving the p38\/SAPK2 Pathway"],"prefix":"10.1006","volume":"280","author":[{"given":"Martina","family":"Vockerodt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Haier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Buttgereit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Tesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Kube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/viro.2000.0768_RF1","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood.V85.4.1063.bloodjournal8541063","article-title":"Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10","volume":"85","author":"Baiocchi","year":"1995","journal-title":"Blood"},{"key":"10.1006\/viro.2000.0768_RF2","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.4049\/jimmunol.158.9.4045","article-title":"Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines","volume":"158","author":"Beatty","year":"1997","journal-title":"J. Immunol."},{"key":"10.1006\/viro.2000.0768_RF3","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1182\/blood.V80.5.1289.1289","article-title":"Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10","volume":"80","author":"Benjamin","year":"1992","journal-title":"Blood"},{"key":"10.1006\/viro.2000.0768_RF4","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood.V82.7.2169.2169","article-title":"Serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor","volume":"82","author":"Blay","year":"1993","journal-title":"Blood"},{"key":"10.1006\/viro.2000.0768_RF5","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.4049\/jimmunol.162.5.2939","article-title":"Selective regulation of cytokine induction by adenoviral gene transfer of IkappaBalpha into human macrophages: Lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-kappaB independent","volume":"162","author":"Bondeson","year":"1999","journal-title":"J. Immunol."},{"key":"10.1006\/viro.2000.0768_RF6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1084\/jem.177.2.295","article-title":"Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10","volume":"177","author":"Burdin","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1006\/viro.2000.0768_RF7","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1073\/pnas.100119497","article-title":"NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells","volume":"97","author":"Cahir-McFarland","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.2000.0768_RF8","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood.V85.9.2516.bloodjournal8592516","article-title":"Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: Lack of correlation with prognosis","volume":"85","author":"Cortes","year":"1995","journal-title":"Blood"},{"key":"10.1006\/viro.2000.0768_RF9","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","article-title":"Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1006\/viro.2000.0768_RF10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.177.2.339","article-title":"Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells","volume":"177","author":"Deacon","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1006\/viro.2000.0768_RF11","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1128\/MCB.16.12.7098","article-title":"Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-kappaB activation","volume":"16","author":"Devergne","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/viro.2000.0768_RF12","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1128\/JVI.72.10.7900-7908.1998","article-title":"Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression","volume":"72","author":"Devergne","year":"1998","journal-title":"J. Virol."},{"key":"10.1006\/viro.2000.0768_RF13","first-page":"42","article-title":"Hodgkin's disease derived cell lines: A review","volume":"5","author":"Drexler","year":"1992","journal-title":"Hum. Cell"},{"key":"10.1006\/viro.2000.0768_RF14","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1128\/JVI.73.2.1023-1035.1999","article-title":"Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2","volume":"73","author":"Eliopoulos","year":"1999","journal-title":"J. Virol."},{"key":"10.1006\/viro.2000.0768_RF15","doi-asserted-by":"crossref","first-page":"16085","DOI":"10.1074\/jbc.274.23.16085","article-title":"Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production","volume":"274","author":"Eliopoulos","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1006\/viro.2000.0768_RF16","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/sj.onc.1201258","article-title":"Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors","volume":"14","author":"Eliopoulos","year":"1997","journal-title":"Oncogene"},{"key":"10.1006\/viro.2000.0768_RF17","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/sj.onc.1201694","article-title":"Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1)","volume":"16","author":"Eliopoulos","year":"1998","journal-title":"Oncogene"},{"key":"10.1006\/viro.2000.0768_RF18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s002510050250","article-title":"Mapping of the human IL10 gene and further characterization of the 5\u2032 flanking sequence","volume":"46","author":"Eskdale","year":"1997","journal-title":"Immunogenetics"},{"key":"10.1006\/viro.2000.0768_RF19","first-page":"1852","article-title":"Expression of interleukin 10 in B lymphocytes of different origin","volume":"7","author":"Finke","year":"1993","journal-title":"Leukemia"},{"key":"10.1006\/viro.2000.0768_RF20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0168-1702(98)00147-6","article-title":"Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers","volume":"60","author":"Fischer","year":"1999","journal-title":"Virus Res."},{"key":"10.1006\/viro.2000.0768_RF21","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1038\/sj.onc.1202144","article-title":"Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions","volume":"17","author":"Floettmann","year":"1998","journal-title":"Oncogene"},{"key":"10.1006\/viro.2000.0768_RF22","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/sj.onc.1201359","article-title":"Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation","volume":"15","author":"Floettmann","year":"1997","journal-title":"Oncogene"},{"key":"10.1006\/viro.2000.0768_RF23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/viro.1996.0452","article-title":"Cytostatic effect of Epstein\u2013Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines","volume":"223","author":"Floettmann","year":"1996","journal-title":"Virology"},{"key":"10.1006\/viro.2000.0768_RF24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4049\/jimmunol.160.2.920","article-title":"Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: Role of the p38 and p42\/44 mitogen-activated protein kinases","volume":"160","author":"Foey","year":"1998","journal-title":"J. Immunol."},{"key":"10.1006\/viro.2000.0768_RF25","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1093\/emboj\/18.11.3064","article-title":"Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins","volume":"18","author":"Gires","year":"1999","journal-title":"EMBO J."},{"key":"10.1006\/viro.2000.0768_RF26","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1093\/emboj\/16.20.6131","article-title":"Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule","volume":"16","author":"Gires","year":"1997","journal-title":"EMBO J."},{"key":"10.1006\/viro.2000.0768_RF27","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4049\/jimmunol.160.3.1116","volume":"160","author":"Hatzivassiliou","year":"1998","journal-title":"J. Immunol."},{"key":"10.1006\/viro.2000.0768_RF28","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V87.7.2918.bloodjournal8772918","article-title":"Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease","volume":"87","author":"Herbst","year":"1996","journal-title":"Blood"},{"key":"10.1006\/viro.2000.0768_RF29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1182\/blood.V80.2.484.484","article-title":"Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease","volume":"80","author":"Herbst","year":"1992","journal-title":"Blood"},{"key":"10.1006\/viro.2000.0768_RF30","first-page":"549","article-title":"The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain","volume":"10","author":"Huen","year":"1995","journal-title":"Oncogene"},{"key":"10.1006\/viro.2000.0768_RF31","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1093\/nar\/22.18.3787","article-title":"Three NF-kappa B sites in the I kappa B-alpha promoter are required for induction of gene expression by TNF alpha","volume":"22","author":"Ito","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1006\/viro.2000.0768_RF32","doi-asserted-by":"crossref","first-page":"12592","DOI":"10.1073\/pnas.94.23.12592","article-title":"The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB","volume":"94","author":"Izumi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.2000.0768_RF33","doi-asserted-by":"crossref","first-page":"11085","DOI":"10.1073\/pnas.93.20.11085","article-title":"Tumor necrosis factor receptor associated factor 2 is a mediator of NF- kappaB activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein","volume":"93","author":"Kaye","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.2000.0768_RF34","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","article-title":"Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation","volume":"90","author":"Kaye","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.2000.0768_RF35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1128\/jvi.69.2.675-683.1995","article-title":"The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues","volume":"69","author":"Kaye","year":"1995","journal-title":"J. Virol."},{"key":"10.1006\/viro.2000.0768_RF36","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1093\/emboj\/16.21.6478","article-title":"Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade","volume":"16","author":"Kieser","year":"1997","journal-title":"EMBO J."},{"key":"10.1006\/viro.2000.0768_RF37","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/emboj\/17.6.1700","article-title":"Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor","volume":"17","author":"Kilger","year":"1998","journal-title":"EMBO J."},{"key":"10.1006\/viro.2000.0768_RF38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1097-2765(00)80013-1","article-title":"The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome","volume":"1","author":"Kim","year":"1997","journal-title":"Mol. Cell."},{"key":"10.1006\/viro.2000.0768_RF39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0145-2126(96)00029-X","article-title":"Promotion of IL8, IL10, TNFalpha and TNFbeta production by EBV infection","volume":"20","author":"Klein","year":"1996","journal-title":"Leukemia Res."},{"key":"10.1006\/viro.2000.0768_RF40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.gene.6363641","article-title":"The AT-rich region between -56 to -66 is important for the promoter activity of interleukin-10 in Epstein-Barr Virus positive Burkitt's lymphoma cells","volume":"1","author":"Kube","year":"1999","journal-title":"Genes Immun."},{"key":"10.1006\/viro.2000.0768_RF41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cyto.1995.1001","article-title":"Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines","volume":"7","author":"Kube","year":"1995","journal-title":"Cytokine"},{"key":"10.1006\/viro.2000.0768_RF42","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/JVI.73.2.1630-1636.1999","article-title":"Expression of Epstein-Barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428","volume":"73","author":"Kube","year":"1999","journal-title":"J. Virol."},{"key":"10.1006\/viro.2000.0768_RF43","doi-asserted-by":"crossref","first-page":"11963","DOI":"10.1073\/pnas.95.20.11963","article-title":"Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice","volume":"95","author":"Kulwichit","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.2000.0768_RF44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.immunol.16.1.471","article-title":"The origin of Hodgkin and Reed\/Sternberg cells in Hodgkin's disease","volume":"16","author":"K\u00fcppers","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1006\/viro.2000.0768_RF45","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1099\/0022-1317-79-9-2117","article-title":"NF-kB only partially mediates Epstein-Barr virus latent membrane protein 1 activation of B cells","volume":"79","author":"Liljeholm","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1006\/viro.2000.0768_RF46","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1073\/pnas.93.13.6716","article-title":"Multivalent DNA binding properties of the HMG-I proteins","volume":"93","author":"Maker","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.2000.0768_RF47","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1182\/blood.V85.12.3423.bloodjournal85123423","article-title":"Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma","volume":"85","author":"Masood","year":"1995","journal-title":"Blood"},{"key":"10.1006\/viro.2000.0768_RF48","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/jvi.71.1.586-594.1997","article-title":"Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation","volume":"71","author":"Miller","year":"1997","journal-title":"J. Virol."},{"key":"10.1006\/viro.2000.0768_RF49","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1128\/jvi.69.5.2968-2976.1995","article-title":"Stimulation of NF-kB-mediated transcription by mutant derivatives of the latent membrane protein of EBV","volume":"69","author":"Mitchell","year":"1995","journal-title":"J. Virol."},{"key":"10.1006\/viro.2000.0768_RF50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.iy.11.040193.001121","article-title":"Interleukin-10","volume":"11","author":"Moore","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"10.1006\/viro.2000.0768_RF51","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1182\/blood.V88.3.1035.bloodjournal8831035","article-title":"Interleukin-10 gene expression in adult T-cell leukemia","volume":"88","author":"Mori","year":"1996","journal-title":"Blood"},{"key":"10.1006\/viro.2000.0768_RF52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0092-8674(95)90489-1","article-title":"The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family","volume":"80","author":"Mosialos","year":"1995","journal-title":"Cell"},{"key":"10.1006\/viro.2000.0768_RF53","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ijc.2910570218","article-title":"The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines","volume":"57","author":"Nakagomi","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1006\/viro.2000.0768_RF54","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood.V90.4.1664","article-title":"Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis","volume":"90","author":"Niedobitek","year":"1997","journal-title":"Blood"},{"key":"10.1006\/viro.2000.0768_RF55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/annonc\/8.suppl_2.S79","article-title":"Normal and malignant B-cell development with special reference to Hodgkin's disease","volume":"2","author":"Rajewsky","year":"1997","journal-title":"Ann. Oncol."},{"key":"10.1006\/viro.2000.0768_RF56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/viro.1997.8901","article-title":"Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation","volume":"240","author":"Roberts","year":"1998","journal-title":"Virology"},{"key":"10.1006\/viro.2000.0768_RF57","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1073\/pnas.89.5.1890","article-title":"Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes","volume":"89","author":"Rousset","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.2000.0768_RF58","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1023\/A:1008301602785","article-title":"Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival","volume":"10","author":"Sarris","year":"1999","journal-title":"Ann. Oncol."},{"key":"10.1006\/viro.2000.0768_RF59","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2141.1994.tb05116.x","article-title":"Prognostic value of serum IL-10 and soluble IL-2 receptor levels in aggressive non-Hodgkin's lymphoma","volume":"88","author":"Stasi","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1006\/viro.2000.0768_RF60","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/08830189809043006","article-title":"Interleukin-10 as a regulatory cytokine induced by cellular stress: Molecular aspects","volume":"16","author":"Stordeur","year":"1998","journal-title":"Int. Rev. Immunol."},{"key":"10.1006\/viro.2000.0768_RF61","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a010607","article-title":"Interleukin 10 inhibits cytokine production of human AML cells","volume":"7","author":"Westermann","year":"1996","journal-title":"Ann. Oncol."},{"key":"10.1006\/viro.2000.0768_RF62","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1002\/j.1460-2075.1996.tb01098.x","article-title":"Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival","volume":"15","author":"Zimber","year":"1996","journal-title":"EMBO J."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682200907682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682200907682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:48:31Z","timestamp":1758581311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682200907682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["S0042682200907682"],"URL":"https:\/\/doi.org\/10.1006\/viro.2000.0768","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Epstein\u2013Barr Virus Latent Membrane Protein 1 Induces Interleukin-10 in Burkitt's Lymphoma Cells but Not in Hodgkin's Cells Involving the p38\/SAPK2 Pathway","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/viro.2000.0768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}